Medipower (Overseas) PCL (XTAE:MDPR) EV-to-EBITDA: (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:MDPR Medipower (Overseas) PCL XTAE:MDPR
20 GF Score
Price ₪5.03
! 2 Warning Signs
View Full Analysis

What is Medipower (Overseas) PCL EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medipower (Overseas) PCL's enterprise value is ₪293.53 Mil. Medipower (Overseas) PCL does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Medipower (Overseas) PCL's EV-to-EBITDA at this moment.

The historical rank and industry rank for Medipower (Overseas) PCL's EV-to-EBITDA or its related term are showing as below:

XTAE:MDPR's EV-to-EBITDA is not ranked *
in the Real Estate industry.
Industry Median: 12.22
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-09-03), Medipower (Overseas) PCL's stock price is ₪5.031499. Medipower (Overseas) PCL does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Medipower (Overseas) PCL's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Medipower (Overseas) PCL  (XTAE:MDPR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medipower (Overseas) PCL's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.031499/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Medipower (Overseas) PCL EV-to-EBITDA Related Terms

Medipower (Overseas) PCL EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Medipower (Overseas) PCL's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipower (Overseas) PCL EV-to-EBITDA Chart

Medipower (Overseas) PCL Annual Data
Trend
EV-to-EBITDA

Medipower (Overseas) PCL Semi-Annual Data
EV-to-EBITDA

XTAE:MDPR vs CBRE, BEKE, JLL: EV-to-EBITDA Comparison

For the Real Estate Services subindustry, Medipower (Overseas) PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipower (Overseas) PCL EV-to-EBITDA vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Medipower (Overseas) PCL's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medipower (Overseas) PCL's EV-to-EBITDA falls into.


XTAE:MDPR
20GF Score
Medipower (Overseas) PCL XTAE:MDPR
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipower (Overseas) PCL EV-to-EBITDA Calculation

Medipower (Overseas) PCL's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=293.527/
=

Medipower (Overseas) PCL Business Description

Address 1-C. Skokou , 6th Floor, Nicosia, CYP, 1061
Medipower (Overseas) PCL is a Cyprus based company which operates in the real estate industry. It owns and manages retail properties, shopping centers and residential developments in the United States, Canada, Sweden, and Bulgaria.
20GF Score

Get the complete analysis for XTAE:MDPR

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪5.03
Price